Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.

CEO

Belén Garijo López

CEOBelén Garijo López

Employees

76,493

Employees76,493

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1973

Founded1973

Employees

76,493

Employees76,493

SNY Key Statistics

Market cap

97.46B

Market cap97.46B

Price-Earnings ratio

20.40

Price-Earnings ratio20.40

Dividend yield

4.44%

Dividend yield4.44%

Average volume

3.57M

Average volume3.57M

High today

$40.50

High today$40.50

Low today

$40.18

Low today$40.18

Open price

$40.37

Open price$40.37

Volume

1.91M

Volume1.91M

52 Week high

$52.68

52 Week high$52.68

52 Week low

$39.07

52 Week low$39.07

SNY News

24/7 Wall St. 42m

Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady

Investing Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady Vaccine stocks are cracking under intense selling pressur...

Simply Wall St 9h

AI Drug Candidate Might Change The Case For Investing In Sanofi - Simply Wall Street

...

Benzinga 12h

Recursion Pharmaceuticals Stock is Trending After Hours: Here’s What You Should Know

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) shares are trending on Friday. Shares of the Utah-based clinical-stage biotechnology company edged 0.24% higher to...

Analyst ratings

50%

of 10 ratings

Buy

50%

Hold

50%

Sell

More SNY News

Benzinga 24h

Sanofi Must Set Record Straight on Rival Flu Shot Under EU Antitrust Deal

Sanofi S.A. (NASDAQ:SNY) has agreed to legally binding commitments to address European Union competition concerns over its alleged campaign against a rival flu...

TipRanks 1d

Recursion Pharmaceuticals Stock Soars 15% on a $10M Milestone Payment from Sanofi

Recursion Pharmaceuticals (RXRX) stock was up on Thursday after the biotechnology firm announced that Sanofi (SNY) has optioned one of its drug candidates. The...

TipRanks 1d

Sanofi, pCPA sign letter of intent for Dupixent across four indications

Sanofi (SNY) announced the successful completion of negotiations between the pan-Canadian Pharmaceutical Alliance and Sanofi with a signed Letter of Intent for...

TipRanks 1d

Recursion announces Sanofi option for development candidate

Recursion (RXRX) announced that Sanofi (SNY) has optioned the first development candidate from the two companies’ multi-program research collaboration. The oral...

TipRanks 2d

Sanofi’s RSV Study in Queensland Offers Fresh Clues on Nirsevimab Uptake

Sanofi SA (SNY) announced an update on their ongoing clinical study. The Sanofi study RSV Immunisation Status in Queensland (Australia) tracks how often infant...

Zacks 2d

Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?

AbbVie (ABBV Quick QuoteABBV - Free Report) and Sanofi (SNY Quick QuoteSNY - Free Report) are major pharmaceutical companies. AbbVie has a strong pr...

TipRanks 2d

EU accepts Sanofi’s concessions to end probe over vaccine marketing

The European Commission has made commitments offered by Sanofi (SNY) legally binding under EU antitrust rules. The commitments relate to the Commission’s prelim...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.